Neuromuscular Blocking Flashcards

1
Q

what may be an effect of ketamine being given alone as an anaesthetic drug?

A

muscle ridgidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what methods can be used to provide muscle relaxation under anaesthesia?

A

local anaesthetics
benzodiazipines
alpha-2 adrenoreceptor agonists
guaiphenesin (GGE)
neuromuscular blocking drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is often sufficient to provide muscle relaxation for most procedures?

A

GA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what type of drug is guaiphenesin (GGE)?

A

centrally acting muscle relaxant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what areas of the body does guaiphenesin (GGE) work at?

A

internuncial neurones of the spinal cord, brainstem and subcortical areas of the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

does guaiphenesin (GGE) have analgesic or anaesthetic properties?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when is guaiphenesin (GGE) most commonly used?

A

infusion during induction
part of a triple for GA maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what species is guaiphenesin (GGE) used in?

A

horses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why is guaiphenesin (GGE) useful in equine anaesthesia?

A

counteracts ketamine muscle rigidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the main considerations for guaiphenesin (GGE)?

A

can cause haemolysis at higher concentrations
can cause tissue damage if given perivascularly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when can guaiphenesin (GGE) cause haemolysis?

A

at concentrations greater than 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what can happen at guaiphenesin (GGE) concentrations greater than 10%?

A

haemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how can tissue necrosis from perivascular guaiphenesin (GGE) administration be prevented?

A

clean stick IVC
patency confirmed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the clinical indications for the use of NMBAs?

A

relax skeletal muscles for surgical access
facilitate control of ventilation
facilitate tracheal intubation in cats and pigs
ophthalmic surgery
assist reduction of dislocated joints and fractures
reduction of anaesthetic needed to relax muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how can relaxation of skeletal muscles by NMBAs increase surgical access?

A

aids retraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how can relaxation of skeletal muscles by NMBAs facilitate control of ventilation?

A

prevents patients bucking the vent which can cause physiological disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how can administration of NMBAs aid ophthalmic surgery?

A

creation of a central and stable eye to aid surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does administration of NMBAs aid reduction of dislocated joints and fractures?

A

can aid closed reduction as muscles will relax and so traction easier to perform

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

when may administration of NMBAs not be of use for fracture or dislocation reduction?

A

if the injury is older and scar tissue has formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

why may NMBAs not be useful in the reduction of old fractures or dislocations?

A

fibrosis will be present which will not be responsive to NMBAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how can NMBAs reduce the amount of anaesthetic drug needed?

A

MAC sparing as less volatile needed to produce muscle relaxation
fewer analgesic drugs needed to produce muscle relaxation so fewer side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what must you ensure about your patient when they are anaesthetised and have a NMBA on board?

A

anaesthetic depth is adequate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the anaesthetic triad?

A

narcosis
analgesia
muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

why were NMBAs initially unsuccessfully used in dogs?

A

patients weren’t ventilated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

describe the process of an impulse passing through the neuromuscular junction

A

acytylcholine (ACh) released from presynaptic neurone due to change in charge of cell
acytylcholine (ACh) passes across synapse and binds to post-synaptic nicotinic receptor
once two acytylcholine (ACh) subunits are bound there is a resulting muscle contraction
acytylcholine (ACh) is then rapidly hydrolysed within the synaptic cleft by acytylcholineesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is the neuromuscular junction formed of?

A

motor neurone
muscle cell
seperated by synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is the role of acytylcholine (ACh)?

A

passes across synapse and binds to muscle cell to instigate muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what receptor on the post synaptic cell does acytylcholine (ACh) bind to?

A

nicotinic receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

how may subunits of the post synaptic nicotinic receptor must be bound to acytylcholine (ACh) in order to stimulate muscle contraction?

A

two

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

how is muscle contraction kept brief?

A

acytylcholine (ACh) is broken down rapidly in synaptic cleft by acytylcholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what enzyme breaks down acytylcholine (ACh)?

A

acytylcholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what is the role of acytylcholinesterase?

A

break down of acytylcholine (ACh) remaining in the synaptic cleft to keep muscle contraction short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what must be available before neuromuscular blocking drugs are given?

A

facilities for ET intubation
IPPV
robust analgesic and anaesthetic protocol
appropriate anaesthetic depth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

why is a robust analgesic and anaesthetic plan vital when NMBAs are used?

A

they have no anaesthetic or analgesic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what muscles are most sensitive to the action of NMBAs?

A

peripheral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what muscles are least sensitive to NMBAs?

A

central - diaphragm and intercostals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

are all muscle groups equally sensitive to NMBAs?

A

no - peripheral much more sensitive and central (e.g. diaphragm and intercostals) much less so

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what are the 2 main groups of NMBAs?

A

depolarizing
non-depolarizing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what is an example of a depolarising NMBA?

A

Suxamethonium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what is Suxamethonium formed from?

A

2 ACh molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

how does Suxamethonium exert its action at the NMJ?

A

administered IV, moves into synaptic cleft down concentration gradient
binds to post synaptic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

how is Suxamethonium broken down by the body?

A

cannot be broken down by acytylcholineesterase in the synapse so moves out of synapse and is broken down in the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

what is Suxamethonium broken down by?

A

pseudocholinesterase / plasma cholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

can Suxamethonium be broken down within the synapse?

A

no - must diffuse out into the plasma and be broken down by pseudocholinesterase / plasma cholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

what is the speed of onset of Suxamethonium?

A

2-3 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

how many doses of Suxamethonium can be given?

A

only one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

what is seen in the patient on initial administration of Suxamethonium?

A

muscle fasiculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

why is muscle fasiculation seen in the patient on initial administration of Suxamethonium?

A

due to the binding of the molecule to the post synaptic cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what can occur if multiple doses of Suxamethonium are given?

A

accumulation leading to phase II block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

how long is the duration of action of Suxamethonium in cats?

A

5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

how long is the duration of action of Suxamethonium in dogs?

A

20 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

how may Suxamethonium be used in cats and pigs?

A

aid intubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

what are some of the risks with using Suxamethonium?

A

may trigger malignant hyperthermia
can increase serum potassium levels and so should not be used with burns patients

54
Q

with what conditions must the use of Suxamethonium be carefully considered?

A

urinary issues
burns
due to raised K+

55
Q

how do non-depolarising NMBAs work?

A

compete with acytylcholine (ACh) for binding sites on the post synaptic cell which prevents binding of endogenous acytylcholine (ACh)

56
Q

how does competative inhibition of acytylcholine (ACh) prevent muscle contraction?

A

prevents binding of endogenous acytylcholine (ACh) and so prevents mscle contraction

57
Q

are initial muscle fasiculations seen with non-depolarizing NMBAs?

A

no as there is no initial binding

58
Q

why are no initial muscle fasiculations seen with non-depolarizing NMBAs?

A

there is no initial binding of the drug to the receptor sites

59
Q

what is the speed of onset of non-depolarizing NMBAs?

A

relatively slow

60
Q

can non-depolarizing NMBAs be topped up?

A

yes with 1/3 of initial dose
or given as an infusion

61
Q

how much can non-depolarizing NMBAs be topped up by?

A

1/3 original dose

62
Q

what is the main safety aspect of non-depolarizing NMBAs?

A

can be antagonised

63
Q

can non-depolarizing NMBAs be antagonised?

A

yes

64
Q

can depolarizing NMBAs be antagonised?

A

no

65
Q

what is the most common non-depolarizing NMBA?

A

atracurium

66
Q

what type of compound is atracurium?

A

bis-isoquinolinium

67
Q

what is atracurium made up of?

A

mixture of 10 isomers

68
Q

how may of the isomers which form atracurium are active?

A

only one

69
Q

what is Hoffman elimination?

A

temperature dependent reaction seen in plasma which is involved in drug metabolism

70
Q

how is atracurium broken down by the body?

A

cannot be broken down in the synapse so diffuses out of cell
some hepatic metabolism
mostly Hoffman elimination

71
Q

is atracurium broken down by acytylcholinesterase?

A

no - cannot be broken down in the synapse so diffuses out of cell
some hepatic metabolism
mostly Hoffman elimination

72
Q

what pre-existing conditions is atracurium suitable for use with?

A

hepatic
renal

73
Q

why is atracurium agent of choice for animals with hepatic or renal compromise?

A

not 100% metabolised by the liver

74
Q

what is a risk when giving atracurium IV?

A

histamine release

75
Q

how can histamine release following atracurium IV administration be avoided?

A

slow IV

76
Q

what compound can be produced by metabolism of atracurium?

A

laudanoustine

77
Q

what is the risk associated with laudanoustine?

A

has neuro effects but not at clinical doses

78
Q

what is cisatracurium?

A

the active isomer in atracurium

79
Q

why is cisatracurium not often used?

A

expensive

80
Q

where should atracurium be stored?

A

the fridge

81
Q

does atracurium need to be reconstituted/

A

no

82
Q

what is vecuronium?

A

non-depolarizing NMBA

83
Q

what type of compound is vecuronium?

A

steroid

84
Q

does vecuronium have corticosteroid effects as it is a steroid compound?

A

no

85
Q

is there a risk of histamine release with vecuronium?

A

no

86
Q

how much vecuronium is metabolised though the liver?

A

40-50% undergoes hepatic metabolism

87
Q

what form is vecuronium supplied in?

A

powder - must be reconstituted

88
Q

how long can reconstituted vecuronium be stored for?

A

24 hours

89
Q

where can vecuronium be stored?

A

shelf

90
Q

what are the 3 other NMBAs?

A

rocuronium
mivacurium
pancuronium

91
Q

what must be monitored about the equipment when the patient is undergoing NMB?

A

ensure ventilator is working and IPPV is resulting in effective ventilation
check tube is not kinked or dislodged
ensure breathing system remains connected

92
Q

what patient parameters are key when monitoring a patient with NMBAs on board?

A

movement of thoracic wall
EtCO2
SpO2

93
Q

why can’t you use traditional methods to check anaesthetic depth when a patient is undergoing a NMB?

A

muscle movement is lost so reflexes cannot be checked and jaw will be lax

94
Q

what are the signs of inadequate anaesthetic depth for the NMBA patient?

A

increase in pulse rate
increase in blood pressure
salivation or lacrimation
vasovagal response
increased EtCO2 unrelated to ventilation change
slight muscle twitching
pupillary dilation

95
Q

what is the vasovagal response?

A

bradycardia
hypotension

96
Q

what parameter is critical when monitoring patients with NMBAs?

A

blood pressure

97
Q

why must a neuromuscular blockade be monitored?

A

to check if the degree of muscle relaxation is adequate

98
Q

how is a neuromuscular blockade monitored?

A

peripheral nerve stimulator used to generate twitches

99
Q

does peripheral nerve stimulation assess anaesthetic depth?

A

no only degree of neuromuscular blockade

100
Q

what nerves can be used for monitoring a neuromuscular blockade?

A

ulnar
peroneal
facial

101
Q

what is the main monitoring method for NMB?

A

train of 4

102
Q

how does train of 4 NMB monitoring work?

A

4 electrical impulses supplied to the nerve over 2 seconds

103
Q

how may electrical impulses are used in train of 4 NMB monitoring?

A

4

104
Q

how long does testing of the NMB last in train of 4 NMB monitoring

A

2 seconds

105
Q

what is the most common NMB monitoring pattern?

A

tain of 4

106
Q

what pattern would be see if a train of four was used in a non-NMB patient?

A

4 twitches of equal strength
large twicthes

107
Q

how does the train of 4 show the effect of an NMBA?

A

as NMBA is administered twitch strength will decline
eventually all should be absent

108
Q

how frequently should the NMB be checked using the train of four?

A

every 5 minutes

109
Q

what factors influence the duration of NMB?

A

volatile agent used
hypothermia
hepatic or renal insufficiency
electrolyte or acid base abnormalities
muscle diseases (e.g. myaesthenia gravis)
aminoglycoside antibiotics
dose of NMBA administered

110
Q

what is the effect of hypothermia on the duration of NMBAs?

A

prolongs action

111
Q

what is the effect of hepatic or renal insufficiency on the duration of NMBAs?

A

prolongs action

112
Q

what is the effect of myesthenia gravis on the duration of NMBAs?

A

prolongs action

113
Q

how does the dose of NMBA adminstered affect NMBA action?

A

higher dose leads to longer action

114
Q

how do aminoglycoside antibiotics affect NMBA action?

A

prolong action

115
Q

what type of NMBAs can be antagonised?

A

non-depolarising

116
Q

when should non-depolarising NMBAs be antagonised?

A

once 1 or 2 twitches return on train of four

117
Q

what type of drug is used to antagonise non-depolarising NMBAs?

A

anticholinesterases

118
Q

why are anticholinesterases used to antagonise non-depolarising NMBAs?

A

interfere with the action of acytycholinesterase and so increase the concentration of acytylcholine (ACh) available in the synapse
this competes with NMBA and eventually there is high enough concentration that muscle contrction will return

119
Q

what do anticholinesterases interfere with?

A

acytylcholinesterases

120
Q

what are the side effects of anticholinesterases?

A

bradycardia
salivation
bronchospasm
diarrhoea

121
Q

why are the side effects of anticholinesterases seen?

A

due to an increase in ACh at other receptors as acytylcholinesterases is inhibited

122
Q

what are the main anticholinesterases used to antagonise NMBAs?

A

neostigmine
edrophonium

123
Q

what type of drugs are given alongside anticholinesterases?

A

anticholinergic

124
Q

when are anticholinergic drugs given?

A

alongside anticholinesterases

125
Q

why are anticholinergic drugs given alongside anticholinesterases?

A

to counteract side effects of anticholinesterases

126
Q

what are the main anticholinergic drugs given alongside anticholinesterases?

A

atropine
glycopyrrolate

127
Q

when can ventilation be stopped in patients where NMBA has been antagonised?

A

must be supported until spontaneous ventilation seen

128
Q

what must be monitored for following extubation of patient who has had a NMBA?

A

URT weakness
return of paralysiswh

129
Q

at may indicate return of paralysis following NMBA antagonism?

A

cyanosis
URT noise
paradoxical ventilation

130
Q

who must be informed if a patient has received a NMBA?

A

recovery and wards nurses

131
Q

what other NMBA and antgonist is available but expensive?

A

rocuronium
cyclodextrins to antagonise

132
Q
A